These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 22324971)

  • 21. Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance.
    Azizi Ghanbari A; Dörr R; Spitzer S; Stumpf J; Britz A; Amann-Zalan I; Lodwig V; Ulm B; Schnell O; Lohmann T
    Diab Vasc Dis Res; 2013 Sep; 10(5):452-8. PubMed ID: 23818456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.
    Abdul-Ghani MA; Williams K; DeFronzo R; Stern M
    Diabetes Care; 2006 Jul; 29(7):1613-8. PubMed ID: 16801587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body mass and atherogenic dyslipidemia as major determinants of blood levels of B-type natriuretic peptides in Arab subjects with acute coronary syndromes.
    Akanji AO; Suresh CG; Al-Radwan R; Fatania HR
    Metab Syndr Relat Disord; 2009 Dec; 7(6):563-9. PubMed ID: 19642911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [An analysis of relationship between the severity of coronary artery lesion and risk factors of cardiovascular events in Tianjin].
    Xiao JY; Zhang HN; Cao L; Cong HL
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Nov; 25(11):650-4. PubMed ID: 24225217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
    Lemieux S; Bédard A; Piché MÈ; Weisnagel SJ; Corneau L; Bergeron J
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?
    Piché ME; Després JP; Pascot A; Nadeau A; Tremblay A; Weisnagel SJ; Bergeron J; Lemieux S
    Diabet Med; 2004 Jul; 21(7):730-7. PubMed ID: 15209766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study.
    Hong Y; Jin X; Mo J; Lin HM; Duan Y; Pu M; Wolbrette DL; Liao D
    J Intern Med; 2007 Jul; 262(1):113-22. PubMed ID: 17598819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
    Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes of the new gaseous transmitter H2S in patients with coronary heart disease].
    Jiang HL; Wu HC; Li ZL; Geng B; Tang CS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):951-4. PubMed ID: 16109547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High sensitive C-reactive protein, adiponectin, and urine albumin excretion rate in Chinese coronary artery disease patients with different glucose tolerance status.
    Gui MH; Hong J; Lü AK; Chen Y; Shen WF; Li XY; Ning G
    Chin Med J (Engl); 2008 Dec; 121(24):2509-16. PubMed ID: 19187587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The relationship between adiponectin and coronary heart disease metabolic risk factors in non-diabetic male patients].
    Li X; Gao X; Zhang B; Zhao NQ
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1971-4. PubMed ID: 17923036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A cross-sectional study on the treatment goals of blood pressure, serum lipids and blood glucose in elderly patients with coronary heart disease].
    Zhu Y; Wang J; Bao Y; Qiao YX; Wu LZ; Li J; Li J; Hu DY
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(21):1479-85. PubMed ID: 21914285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between serum lipids and 1-hour postload plasma glucose levels in normoglycemic individuals.
    Shimodaira M; Niwa T; Nakajima K; Kobayashi M; Hanyu N; Nakayama T
    J Clin Lipidol; 2014; 8(2):217-22. PubMed ID: 24636182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abdominal fat distribution and serum lipids in patients with and without coronary heart disease.
    Sadeghi M; Pourmoghaddas Z; Hekmatnia A; Sanei H; Tavakoli B; Tchernof A; Roohafza H; Sarrafzadegan N
    Arch Iran Med; 2013 Mar; 16(3):149-53. PubMed ID: 23432166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal Glucose Absorption Is a Key Determinant of 1-Hour Postload Plasma Glucose Levels in Nondiabetic Subjects.
    Tricò D; Mengozzi A; Frascerra S; Scozzaro MT; Mari A; Natali A
    J Clin Endocrinol Metab; 2019 Jun; 104(6):2131-2139. PubMed ID: 30445459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond fasting plasma glucose: the association between coronary heart disease risk and postprandial glucose, postprandial insulin and insulin resistance in healthy, nondiabetic adults.
    Bhat SL; Abbasi FA; Blasey C; Reaven GM; Kim SH
    Metabolism; 2013 Sep; 62(9):1223-6. PubMed ID: 23809477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
    Miller M; Zhan M; Havas S
    Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels.
    Succurro E; Marini MA; Grembiale A; Lugarà M; Andreozzi F; Sciacqua A; Hribal ML; Lauro R; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2009 May; 25(4):351-6. PubMed ID: 19319930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
    Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association analysis between endothelial function related factors and coronary artery stenosis degree in coronary heart disease patients with type 2 diabetes mellitus.
    Li Q; Zhang Z; Du R; Hu X; Yan Y; Gao Q; Fan Y
    J Pediatr Endocrinol Metab; 2012; 25(7-8):711-6. PubMed ID: 23155698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.